Shan Xu
- Molecular Biology top 2%
- Epidemiology top 2%
- Organic Chemistry top 2%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Mariusz KarbowskiDer‐Fen SuenMegan M. ClelandDerek P. NarendraAtsushi TanakaRichard J. YoulePengwu ZhengDalin He
- Topics
- PI3K/AKT/mTOR signaling in cancer (22 papers)Lung Cancer Treatments and Mutations (19 papers)Synthesis and biological activity (16 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Shan Xu
162 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Molecular Biology 3.3k
- Epidemiology 1.1k
- Organic Chemistry 726
- Oncology 606
- Cancer Research 602
Countries citing papers authored by Shan Xu
This map shows the geographic impact of Shan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Xu more than expected).
Fields of papers citing papers by Shan Xu
This network shows the impact of papers produced by Shan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Xu. The network helps show where Shan Xu may publish in the future.
Co-authorship network of co-authors of Shan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Shan Xu. A scholar is included among the top collaborators of Shan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Xu. Shan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 21 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 9 | |
| 7 | 7 | |
| 8 | 11 | |
| 9 | 17 | |
| 10 | 25 | |
| 11 | 55 | |
| 12 | 36 | |
| 13 | 24 | |
| 14 | 28 | |
| 15 | 0 | |
| 16 | 34 | |
| 17 | [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. | 12 |
| 18 | 211 | |
| 19 | 34 | |
| 20 | 366 |
About Shan Xu
Shan Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 171 papers that have together received 5.6k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (22 papers), Lung Cancer Treatments and Mutations (19 papers) and Synthesis and biological activity (16 papers). The work is most often cited by research in Molecular Biology (3.3k citations), Cancer Research (602 citations) and Clinical Biochemistry (266 citations). Shan Xu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Mariusz Karbowski, Der‐Fen Suen, Megan M. Cleland, Derek P. Narendra, Atsushi Tanaka, Richard J. Youle, Pengwu Zheng, Dalin He, Wufu Zhu and Peng Guo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.